Jun 8, 2026 07:01AM

Jun 2, 2026 08:00AM

Apr 30, 2026 07:03AM

Jan 22, 2026 04:09PM

Jan 5, 2026 07:02AM

Dec 15, 2025 07:03AM

Nov 4, 2025 12:02PM RedHill Biopharma secures final $10.5 million court judgment

Nov 4, 2025 09:30AM

Oct 22, 2025 04:51PM

Oct 20, 2025 09:05AM

Oct 6, 2025 08:01AM

Sep 29, 2025 07:02AM

Aug 20, 2025 09:03AM

Aug 18, 2025 09:03AM RedHill receives $1.1 million in licensing payments for Talicia

Jul 21, 2025 09:01AM

Jul 1, 2025 12:01PM

Apr 28, 2025 07:05AM

Apr 17, 2025 04:08PM

Apr 16, 2025 07:02AM

Mar 18, 2025 07:00AM

Feb 25, 2025 07:04AM RedHill Biopharma (RDHL) Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

Feb 4, 2025 07:02AM

Dec 10, 2024 07:06AM

Dec 2, 2024 07:00AM

Oct 22, 2024 07:01AM

Oct 14, 2024 07:01AM

Oct 1, 2024 07:08AM

Sep 30, 2024 07:05AM RedHill (RDHL) Announces New U.S. Coronavirus Patent for Opaganib, Valid Through 2041

Sep 5, 2024 07:01AM

Sep 3, 2024 07:06AM

Aug 26, 2024 07:00AM

Aug 19, 2024 07:00AM

Aug 16, 2024 07:01AM

Jul 22, 2024 07:02AM

Jul 9, 2024 08:04AM RedHill Biopharma (RDHL) Terminates License Agreement for Aemcolo

416,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All